Allemani C, Weir HK, Carreira H et al. . Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 2015;385:977–1010.
Berry DA, Cronin KA, Plevritis SK et al. . Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784–1792.
DeSantis CE, Bray F, Ferlay J et al. . International variation in female breast cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev 2015;24:1495–1506.
Saadatmand S, Bretveld R, Siesling S et al. . Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients. BMJ 2015;351:h4901.
Berry DA, Cirrincione C, Henderson IC et al. . Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA 2006;295:1658–1667.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687–1717.
Chavez-MacGregor M, Clarke CA, Lichtensztajn DY et al. . Delayed initiation of adjuvant chemotherapy among patients with breast cancer. JAMA Oncol 2016;2:322–329.
Colleoni M, Gelber RD. Time to initiation of adjuvant chemotherapy for early breast cancer and outcome: the earlier, the better? J Clin Oncol 2014;32:717–719.
Farolfi A, Scarpi E, Rocca A et al. . Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer. Eur J Cancer 2015;51:1874–1881.
Gagliato Dde M, Gonzalez-Angulo AM, Lei X et al. . Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. J Clin Oncol 2014;32:735–744.
Lohrisch C, Paltiel C, Gelmon K et al. . Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol 2006;24:4888–4894.
Yu KD, Huang S, Zhang JX et al. . Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis. BMC Cancer 2013;13:240.
Golshan M, Losk K, Kadish S et al. . Understanding process-of-care delays in surgical treatment of breast cancer at a comprehensive cancer center. Breast Cancer Res Treat 2014;148:125–133.
Senkus E, Kyriakides S, Penault-Llorca F et al. . Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24(Suppl 6):vi7–23.
Desch CE, McNiff KK, Schneider EC et al. . American Society of Clinical Oncology/National Comprehensive Cancer Network quality measures. J Clin Oncol 2008;26:3631–3637.
Cold S, During M, Ewertz M et al. . Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG). Br J Cancer 2005;93:627–632.
Shannon C, Ashley S, Smith IE. Does timing of adjuvant chemotherapy for early breast cancer influence survival? J Clin Oncol 2003;21:3792–3797.
Bleicher RJ, Ruth K, Sigurdson ER et al. . Time to surgery and breast cancer survival in the United States. JAMA Oncol 2016;2:330–339.
Liederbach E, Sisco M, Wang C et al. . Wait times for breast surgical operations, 2003-2011: a report from the National Cancer Data Base. Ann Surg Oncol 2015;22:899–907.
Vandergrift JL, Niland JC, Theriault RL et al. . Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions. J Natl Cancer Inst 2013;105:104–112.
Alderman AK, Collins ED, Schott A et al. . The impact of breast reconstruction on the delivery of chemotherapy. Cancer 2010;116:1791–1800.
Barry PN, Riley EC, Pan J et al. . Delay of adjuvant chemotherapy after elective mastectomy and immediate reconstruction in breast-conservation candidates: a matched-pair analysis. Am J Clin Oncol 2014;37:575–579.
Fedewa SA, Ward EM, Stewart AK et al. . Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006. J Clin Oncol 2010;28:4135–4141.
Freedman RA, He Y, Winer EP et al. . Racial/Ethnic differences in receipt of timely adjuvant therapy for older women with breast cancer: are delays influenced by the hospitals where patients obtain surgical care? Health Serv Res 2013;48:1669–1683.
Lee J, Lee SK, Kim S et al. . Does immediate breast reconstruction after mastectomy affect the initiation of adjuvant chemotherapy? J Breast Cancer 2011;14:322–327.
Sharpe SM, Liederbach E, Czechura T et al. . Impact of bilateral versus unilateral mastectomy on short term outcomes and adjuvant therapy, 2003-2010: a report from the National Cancer Data Base. Ann Surg Oncol 2014;21:2920–2927.